Literature DB >> 21722019

Reduced hippocampal volumes in healthy carriers of brain-derived neurotrophic factor Val66Met polymorphism: meta-analysis.

Tomas Hajek1, Miloslav Kopecek, Cyril Höschl.   

Abstract

OBJECTIVES: Converging evidence suggests that the brain-derived neurotrophic factor (BDNF) gene Val66Met polymorphism affects brain structure. Yet the majority of studies have shown no effect of this polymorphism on hippocampal volumes, perhaps due to small effect size.
METHODS: We performed a meta-analysis of studies investigating the association between Val66Met BDNF polymorphism and hippocampal volumes in healthy subjects by combining standardized differences between means (SDM) from individual studies using random effect models.
RESULTS: Data from 399 healthy subjects (255 Val-BDNF homozygotes and 144 carriers of at least one Met-BDNF allele) in seven studies were meta-analysed. Both the left and right hippocampi were significantly larger in Val-BDNF homozygotes than in carriers of at least one Met-BDNF allele (SDM = 0.41, 95% Confidence Interval = 0.20; 0.62, z = 3.86, P = 0.0001; SDM = 0.41; 95% Confidence Interval = 0.20; 0.61, z = 3.81, P = 0.0001, respectively), with no evidence of publication bias.
CONCLUSIONS: Healthy carriers of BDNF gene Val66Met polymorphism show bilateral hippocampal volume reduction. The effect size was small, but the same direction of effect was seen in all meta-analyzed studies. The association with the BDNF gene Val66Met polymorphism makes hippocampal volume a potential candidate for an endophenotype of disorders presenting with reduced hippocampal volumes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21722019      PMCID: PMC4831902          DOI: 10.3109/15622975.2011.580005

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  51 in total

1.  Spurious genetic associations.

Authors:  Patrick F Sullivan
Journal:  Biol Psychiatry       Date:  2007-03-08       Impact factor: 13.382

2.  Disturbances in selective information processing associated with the BDNF Val66Met polymorphism: evidence from cognition, the P300 and fronto-hippocampal systems.

Authors:  Peter R Schofield; Leanne M Williams; Robert H Paul; Justine M Gatt; Kerri Brown; Agnes Luty; Nicholas Cooper; Stuart Grieve; Carol Dobson-Stone; Charlotte Morris; Stacey A Kuan; Evian Gordon
Journal:  Biol Psychol       Date:  2008-09-16       Impact factor: 3.251

Review 3.  Adult hippocampal neurogenesis: regulation, functional implications, and contribution to disease pathology.

Authors:  Darrick T Balu; Irwin Lucki
Journal:  Neurosci Biobehav Rev       Date:  2008-08-19       Impact factor: 8.989

Review 4.  Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease.

Authors:  Akira Yoshii; Martha Constantine-Paton
Journal:  Dev Neurobiol       Date:  2010-04       Impact factor: 3.964

5.  No association of the Val66Met polymorphism of the brain-derived neurotrophic factor with hippocampal volume in major depression.

Authors:  Frank Jessen; Anna Schuhmacher; Ole von Widdern; Vera Guttenthaler; Susanne Hofels; Husam Suliman; Lukas Scheef; Wolfgang Block; Horst Urbach; Wolfgang Maier; Astrid Zobel
Journal:  Psychiatr Genet       Date:  2009-04       Impact factor: 2.458

6.  Neuronal correlates of brain-derived neurotrophic factor Val66Met polymorphism and morphometric abnormalities in bipolar disorder.

Authors:  Koji Matsuo; Consuelo Walss-Bass; Fabiano G Nery; Mark A Nicoletti; John P Hatch; Benicio N Frey; Emel S Monkul; Giovana B Zunta-Soares; Charles L Bowden; Michael A Escamilla; Jair C Soares
Journal:  Neuropsychopharmacology       Date:  2009-03-18       Impact factor: 7.853

7.  Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression.

Authors:  L Pezawas; A Meyer-Lindenberg; A L Goldman; B A Verchinski; G Chen; B S Kolachana; M F Egan; V S Mattay; A R Hariri; D R Weinberger
Journal:  Mol Psychiatry       Date:  2008-03-18       Impact factor: 15.992

8.  Lower hippocampal volume in patients suffering from depression: a meta-analysis.

Authors:  Stephanie Campbell; Michael Marriott; Claude Nahmias; Glenda M MacQueen
Journal:  Am J Psychiatry       Date:  2004-04       Impact factor: 18.112

9.  The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function.

Authors:  Michael F Egan; Masami Kojima; Joseph H Callicott; Terry E Goldberg; Bhaskar S Kolachana; Alessandro Bertolino; Eugene Zaitsev; Bert Gold; David Goldman; Michael Dean; Bai Lu; Daniel R Weinberger
Journal:  Cell       Date:  2003-01-24       Impact factor: 41.582

10.  The association of genotypic combination of the DRD3 and BDNF polymorphisms on the adhesio interthalamica and medial temporal lobe structures.

Authors:  Tsutomu Takahashi; Michio Suzuki; Masahiko Tsunoda; Yukiko Kawamura; Nagahide Takahashi; Nobuhisa Maeno; Yasuhiro Kawasaki; Shi-Yu Zhou; Hirofumi Hagino; Lisha Niu; Hiroshi Tsuneki; Soushi Kobayashi; Toshiyasu Sasaoka; Hikaru Seto; Masayoshi Kurachi; Norio Ozaki
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2008-03-25       Impact factor: 5.067

View more
  40 in total

1.  APOE-epsilon4 and aging of medial temporal lobe gray matter in healthy adults older than 50 years.

Authors:  Joy L Taylor; Blake K Scanlon; Michelle Farrell; Beatriz Hernandez; Maheen M Adamson; J Wesson Ashford; Art Noda; Greer M Murphy; Michael W Weiner
Journal:  Neurobiol Aging       Date:  2014-05-15       Impact factor: 4.673

Review 2.  The BDNF gene Val66Met polymorphism as a modifier of psychiatric disorder susceptibility: progress and controversy.

Authors:  M Notaras; R Hill; M van den Buuse
Journal:  Mol Psychiatry       Date:  2015-03-31       Impact factor: 15.992

Review 3.  Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents.

Authors:  Ronald S Duman; Bhavya Voleti
Journal:  Trends Neurosci       Date:  2012-01       Impact factor: 13.837

4.  Neuroprogressive effects of lifetime illness duration in older adults with bipolar disorder.

Authors:  Ariel G Gildengers; Kuo-Hsuan Chung; Shou-Hung Huang; Amy Begley; Howard J Aizenstein; Shang-Ying Tsai
Journal:  Bipolar Disord       Date:  2014-04-10       Impact factor: 6.744

5.  A Load to Find Clinically Useful Biomarkers for Depression.

Authors:  Matea Nikolac Perkovic; Marina Sagud; Lucija Tudor; Marcela Konjevod; Dubravka Svob Strac; Nela Pivac
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 6.  Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression.

Authors:  P Licznerski; R S Duman
Journal:  Neuroscience       Date:  2012-10-02       Impact factor: 3.590

7.  Effect of the BDNF Val66Met polymorphism on regional gray matter volumes and cognitive function in the Chinese population.

Authors:  Mu-En Liu; Chu-Chung Huang; Mu-Hong Chen; Albert C Yang; Pei-Chi Tu; Heng-Liang Yeh; Chen-Jee Hong; Jin-Fan Chen; Jen-Ping Hwang; Ching-Po Lin; Shih-Jen Tsai
Journal:  Neuromolecular Med       Date:  2013-12-24       Impact factor: 3.843

Review 8.  Brain-Derived Neurotrophic Factor: Three Ligands, Many Actions.

Authors:  Barbara L Hempstead
Journal:  Trans Am Clin Climatol Assoc       Date:  2015

9.  The Role of Neurotrophins in Major Depressive Disorder.

Authors:  Cheng Jiang; Stephen R Salton
Journal:  Transl Neurosci       Date:  2013-03-01       Impact factor: 1.757

10.  The mouse-equivalent of the human BDNF VAL66MET polymorphism increases dorsal hippocampal volume and does not interact with developmental ethanol exposure.

Authors:  Clark W Bird; Megan J Barber; Jack Martin; Jacob J Mayfield; C Fernando Valenzuela
Journal:  Alcohol       Date:  2020-03-27       Impact factor: 2.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.